Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections in hospitalized patients, including those caused by multidrug‑resistant organisms.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious infections that require intravenous therapy.

- Complicated intra‑abdominal infection: provides coverage against Gram‑negative, Gram‑positive and anaerobic bacteria. - Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: targets resistant respiratory pathogens. - Complicated urinary tract infection: eradicates multidrug‑resistant uropathogens. - Sepsis and septic shock: delivers rapid bactericidal activity in systemic infections. - Meningitis caused by susceptible organisms: penetrates the cerebrospinal fluid to treat central nervous system infections.

Meropenem may cause a range of adverse reactions, most of which are dose‑independent.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and occasionally associated with Clostridioides difficile. - Headache: transient and usually resolves without intervention. - Injection site pain: localized discomfort at the infusion site. - Elevated liver enzymes: transient increase in transaminases. - Rash: mild erythematous skin eruption.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with renal impairment or high doses. - Hemolytic anemia: immune‑mediated destruction of red blood cells. - Thrombocytopenia: reduced platelet count that may increase bleeding risk. - Acute interstitial nephritis: inflammation of kidney interstitium. - Stevens‑Johnson syndrome: rare severe mucocutaneous reaction.

When using Meropenem, clinicians should consider several safety measures.

- Renal function: adjust dose in patients with impaired kidney function. - History of seizures: monitor closely as the drug can lower seizure threshold. - Allergies: avoid in individuals with known hypersensitivity to carbapenems or beta‑lactams. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Concomitant nephrotoxic drugs: monitor renal parameters when combined with other nephrotoxic agents. - Store below 25°C: keep in the original container, protect from moisture and light.

Meropenem can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Valproic acid: concomitant use may reduce valproate levels and increase seizure risk. - Probenecid: may decrease renal clearance of meropenem, leading to higher plasma concentrations.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxic potential requires renal function monitoring. - Loop diuretics: may enhance ototoxicity when used with other ototoxic agents. - Anticoagulants (e.g., warfarin): monitor INR as infection control may alter coagulation parameters.